BP-lowering treatment for patients with type 2 diabetes associated with improved mortality

the ONA take:

According to a new study published in JAMA, researchers have found that blood pressure-lowering treatment in patients with type 2 diabetes is associated with a decreased risk of cardiovascular disease and cardiovascular disease events, coronary heart disease events, and mortality.

For the meta-analysis, researchers identified 40 randomized controlled trials of blood pressure-lowering therapy conducted between 1966 and 2014 that included over 100,000 participants in order to investigate the associations between blood pressure-lowering treatment and cardiovascular disease in patients with type 2 diabetes. 

Researchers found that each 10mm Hg lowering of systolic blood pressure was linked with a lower risk of cardiovascular disease events, coronary heart disease events, mortality, stroke, retinopathy, and albuminuria. Researchers did not find a significant difference in associations between blood-pressure lowering treatments and outcomes except for heart failure and stroke.

Results showed that blood pressure reduction below 130mm Hg was associated with a decreased risk of albuminuria, retinopathy, and stroke, but most outcomes had a decreased risk when systolic blood pressure was below 140mm Hg.

The findings supports current guideline recommendations that patients with type 2 diabetes be treated with antihypertensive therapy when their systolic blood pressure is above 140mm Hg.

Diabetes at midlife influences risk of diabetes and cognitive decline in later years
Blood pressure-lowering treatment in patients with type 2 diabetes is associated with a decreased risk of cardiovascular disease.
Blood pressure-lowering treatment among patients with type 2 diabetes is associated with a lower risk of cardiovascular disease (CVD) and heart disease events and improved mortality, according to a study in the February 10 issue of JAMA.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs